ÂÜÀòÂÒÂ×

Michael R. Gralinski has over 30 years of professional experience in the biopharmaceutical industry. From 1992 to 1996, they worked in R&D roles at the University of Michigan, Parke-Davis, Searle Pharmaceuticals/Monsanto, and Pharmacia/Pfizer. In 2004, they were elected to multiple positions on the Executive Council and Board of Directors of the Safety Pharmacology Society, including Treasurer, Vice President, and President. In 2014, they co-founded Harmony 4 Hope, a Chicago based charitable organization, and held the position of Vice President and Board Director. Michael R. also served as the Master of Ceremonies for Rare Storytellers - a harmony4hope production in 2018. In 2019, they became the Founder of Cor3D Biosciences and the Principal Consultant of CorSolutions. Since 2002, they have been the CEO and Co-Founder of CorDynamics, where they leverage their professional experience to help biopharmaceutical clients address their cardiovascular discovery and safety questions throughout the drug development process.

Michael R. Gralinski received their B.S. in Pharmacology & Toxicology from the University of Wisconsin-Madison and their Ph.D. in Pharmacology (Cardiovascular) from the University of Michigan.